Injectable hydrogel for sustained protein release by salt-induced association of hyaluronic acid nanogel.
Macromol Biosci · 2012
Last updated 2026-05-28Researchers developed a gel made from hyaluronic acid that can carry and slowly release protein-based drugs like exendin-4, which is used in GLP-1 medications. In rats, this gel kept drug levels steady in the blood for a full week after a single injection. The gel forms naturally when mixed with salt and does not damage the proteins it carries.
AI summary of the abstract below.
| Journal | Macromol Biosci, 2012 |
|---|---|
| Citations | 64 |
| Relative citation ratio | 2.36 |
| NIH percentile | 78 |
| Molecules | — |
Abstract
A hyaluronic acid-based anionic nanogel formed by self-assembly of cholesteryl-group-bearing HA is designed for protein delivery. The HA nanogel spontaneously binds various types of proteins without denaturation, such as recombinant human growth hormone, erythropoietin, exendin-4, and lysozyme. The HA nanogel shows unique colloidal properties, in particular that an injectable hydrogel is formed by salt-induced association of the HA nanogel. A pharmacokinetic study in rats shows that an in situ gel formulation, prepared by simply mixing rhGH and HA nanogel in phosphate buffer, maintains plasma rhGH levels within a narrow range over one week. Therefore, HA nanogels offer a simple method for easy formulation of therapeutic proteins and are effective for sustained protein release systems.
Verbatim abstract via PubMed 22606703 ↗